You are seeing headlines and teasers. The full text, sources, and verification note come with the subscription.
Pieces marked Example are fictional placeholders for this demo. They are not reports of real studies.
Neuro-oncology16 November 2026ExampleVerified
A fictional screen says a kinase inhibitor slowed growth in some patient-derived glioma organoids and not others. The example refuses to call that a treatment result. Not a real screen.
2 min read · Headline and teaser · 2 sources
Dementia12 November 2026ExampleVerified
A made-up cohort study claims a four-protein blood panel tracked amyloid PET in people without symptoms. This example shows how a briefing would separate the claim, the design, and the limits. It is not a real study.
2 min read · Headline and teaser · 2 sources
Stroke10 November 2026ExampleVerified
A fictional randomized trial reports a benefit for thrombectomy out to 24 hours in a narrowly selected group. The example briefing keeps the imaging criteria beside the headline result. Not a real trial.
2 min read · Headline and teaser · 2 sources
Headache8 November 2026ExampleCorrected
A corrected example: an earlier draft of this placeholder overstated a fictional head-to-head of two migraine antibodies. The text below is the revised version, marked corrected. Not a real comparison.
2 min read · Headline and teaser · 2 sources
Movement6 November 2026ExampleVerified
A fictional cross-sectional study reports phosphorylated alpha-synuclein in skin biopsies from people with REM sleep behavior disorder. The example keeps the assay claim separate from a prediction of who will convert. Not a real cohort.
1 min read · Headline and teaser · 2 sources
Systems4 November 2026ExampleVerified
A small fictional overnight study links spindle density after a word-pair task with next-day recall. The example is explicit about the sample of 28 and about what a correlation is not. Not a real experiment.
1 min read · Headline and teaser · 1 source